The COVID-19 pandemic, caused by the SARS-CoV-2 virus, poses grave threats to both the
global economy and health. The predominant diagnostic screens in use for SARS-CoV-2
detection are molecular techniques such as nucleic acid amplification tests. In this
Review, we compare current and emerging isothermal diagnostic methods for COVID-19. We
outline the molecular and serological techniques currently being used to detect
SARS-CoV-2 infection, past or present, in patients. We also discuss ongoing research on
isothermal techniques, CRISPR-mediated detection assays, and point-of-care diagnostics
that have potential for use in SARS-CoV-2 detection. Large-scale viral testing during a
global pandemic presents unique challenges, chief among them the simultaneous need for
testing supplies, durable equipment, and personnel in many regions worldwide, with each
of these regions possessing testing needs that vary as the pandemic progresses. The
low-cost isothermal technologies described in this Review provide a promising means by
which to address these needs and meet the global need for testing of symptomatic
individuals as well as provide a possible means for routine testing of asymptomatic
individuals, providing a potential means of safely enabling reopenings and early
monitoring of outbreaks.